ClinicalTrials.Veeva

Menu

An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)

I

Institute of Hematology & Blood Diseases Hospital, China

Status

Enrolling

Conditions

RSV Infection

Treatments

Other: RSV infection observation cohort

Study type

Observational

Funder types

Other

Identifiers

NCT06490549
IIT2023069

Details and patient eligibility

About

This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Aged ≥ 18 years old. 2) Receiving hematopoietic stem cell transplantation; OR being diagnosed with hematological malignancies (including but not limited to leukemia, lymphoma, and multiple myeloma) and receiving chemotherapy.

    2. New onset of respiratory symptoms; OR exacerbation of existing chronic respiratory symptoms (such as previously diagnosed chronic runny nose, seasonal allergies, chronic lung disease, etc.).

    3. Willing to sign an informed consent form, able to understand and willing to follow the study protocol.

Exclusion criteria

  • Unwillingness to sign an informed consent form.

Trial contacts and locations

1

Loading...

Central trial contact

Erlie Jiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems